IP Library Granted Patent US 11,751,858
Granted Patent B2
US 11,751,858 · App. 16/745,209 · Granted Sep 12, 2023

Occlusion device and method for its manufacture

Inventors: Robert Moszner (Bad-Klosterlausnitz, DE); Hans-Reiner Figulla (Jena, DE); Friedrich Moszner (Hohlstedt, DE); Florian Krizanic (Jena, DE)
Assignee: Occlutech GmbH
A61B17/0057A61B17/12109A61B17/12122A61B17/12172D04C1/06D04C3/48A61B17/12022A61B2017/00004A61B2017/00526A61B2017/00575A61B2017/00592A61B2017/00606A61B2017/00615A61B2017/00623A61B2017/00867D10B2509/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,751,858
App. No.
16/745,209
Granted
Sep 12, 2023
Kind
B2
Abstract

The present invention relates to an occlusion device ( 1 ) consisting of a braiding ( 2 ) of thin wires or threads ( 4 ) which is given a suitable form in a molding and heat treatment procedure. The occlusion device ( 1 ) has a proximal retention area ( 6 ) and a distal retention area ( 8 ), whereby the ends of the wires or threads ( 4 ) converge into a holder ( 5 ) in distal retention area ( 8 ). A cylindrical crosspiece ( 10 ) is furthermore disposed between the proximal and distal retention areas ( 6, 8 ). With the objective of providing an occlusion device which positions as flat as possible against the septum at the proximal side of a septal defect in the inserted state, the invention provides for the proximal retention area ( 6 ) of the braiding ( 2 ) to exhibit a completely closed proximal wall ( 112 ) disposed with a continuous surface at the proximal end of the occlusion device ( 1 ) which forms the proximal end ( 12 ) of said occlusion device ( 1 ).

Claims (25)

1. A base body for fabricating a medical implantable device, the base body having a first end and a second end, the base body comprising:

a braiding made of wires, each wire having a length extending between two ends, the braiding having a sack shape including a tapered end, wherein the sack shape comprises a single layer defining a substantially enclosed interior cavity,

wherein, the wires are intertwined from a middle region of said length in a direction outward from a center region of the first end of said base body towards the second end of said base body, and wherein said ends of said wires are converged at said second end of said base body only; and,

wherein the base body is configured to form the medical implantable device after heat setting, the medical implantable device comprising a distal retention area at the first end of the base body opposite the tapered end.

2. The base body according to claim 1 , wherein the first end of the base body comprises a braided wall at the first end of the braiding.

3. The base body according to claim 1 , wherein the braiding has a completely closed braided wall with a continuous surface at the first end of the braiding.

4. The base body according to claim 1 , wherein the braiding has a completely closed braided wall and a continuous surface.

5. The base body according to claim 1 , wherein the braiding is free of discontinuities resulting in a continuous surface.

6. The base body according to claim 1 , wherein all ends of the braiding are welded together at said second end of said base body.

7. The base body according to claim 1 , wherein the first end of the base body forms a braided wall that is perpendicular to a longitudinal axis extending through a center of the base body.

8. The base body of claim 1 , wherein the medical implantable device further comprises a proximal retention area and a cylindrical crosspiece disposed between the distal retention area and the proximal retention area, the cylindrical crosspiece having a diameter which is less than a diameter of each of the proximal retention area and the distal retention area.

9. An implantable occlusion device fabricated from a base body having a first end and a second end, the base body comprising a braiding made of wires, each wire having a length with a middle region and two ends, the braiding having a sack shape including a tapered end, wherein the sack shape comprises a single layer defining a substantially enclosed interior cavity;

wherein the wires are intertwined from their middle region and braided in a direction outward from a center region of the first end towards the second end;

wherein the base body is heat set into a deployment configuration for said implantable occlusion device, the deployment configuration comprising a distal retention area at the first end of the base body opposite the tapered end; and,

wherein each of the ends of the wires converge at the second end in a fixation.

10. The implantable occlusion device according to claim 9 , wherein all ends of the braiding are welded together at said second end of said base body.

11. The implantable occlusion device according to claim 9 , wherein the first end of the base body comprises a braided wall at the first end of the braiding.

12. The implantable occlusion device according to claim 9 , wherein the braiding has a completely closed braided wall with a continuous surface at the first end of the braiding.

13. The implantable occlusion device according to claim 9 , wherein the braiding has a completely closed braided wall and a continuous surface.

14. The implantable occlusion device according to claim 9 , wherein the braiding is free of discontinuities resulting in a continuous surface of the braiding of said implantable occlusion device.

15. The implantable occlusion device according to claim 9 , wherein the implantable occlusion device is an atrial septal defect (ASD) occlusion device.

16. The implantable occlusion device according to claim 9 , wherein the implantable occlusion device is a patent foramen ovale (PFD) occlusion device.

17. The implantable occlusion device according to claim 9 , wherein the implantable occlusion device is a persistent ductus arteriosus (PDA) occlusion device.

18. The implantable occlusion device according to claim 9 , wherein the implantable occlusion device is a ventricular septal defect (VSD) occlusion device.

19. The implantable occlusion device of claim 9 , wherein the deployment configuration further comprises a proximal retention area and a cylindrical crosspiece disposed between the distal retention area and the proximal retention area, the cylindrical crosspiece having a diameter which is less than a diameter of each of the proximal retention area and the distal retention area.

Assignments (2)
SECURITY INTEREST Recorded Sep 19, 2023
From: OCCLUTECH GMBH
To: NORDIC TRUSTEE & AGENCY AB
Reel/Frame 064953/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2023
From: OCCLUTECH HOLDING AG
To: OCCLUTECH GMBH
Reel/Frame 064345/0754 →
Priority Claims (1)
DE 102006013770.1 · Mar 24, 2006 · national
Continuity (4)
Continuation 15357394 · Nov 21, 2016
Continuation 12843788 · Jul 26, 2010
Continuation 11689550 · Mar 22, 2007
Related Publication 20200146662A1 · May 14, 2020
Cited By (1)
US 12,357,287